# Special Session

PMC · DOI: 10.1111/ene.70232 · European Journal of Neurology · 2025-06-21

## Full-text entities

- **Genes:** CXADRP1 (CXADR pseudogene 1) [NCBI Gene 653108] {aka CAR, CXADRP}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, CALCA (calcitonin related polypeptide alpha) [NCBI Gene 796] {aka CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, GBA1 (glucosylceramidase beta 1) [NCBI Gene 2629] {aka GBA, GCB, GLUC}, PLAT (plasminogen activator, tissue type) [NCBI Gene 5327] {aka T-PA, TPA}, ADCYAP1 (adenylate cyclase activating polypeptide 1) [NCBI Gene 116] {aka PACAP}, CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, FCGRT (Fc gamma receptor and transporter) [NCBI Gene 2217] {aka FCRN, FcgammaRn, alpha-chain}, CNTN1 (contactin 1) [NCBI Gene 1272] {aka CMYO12, CMYP12, F3, GP135, MYPCN}, CNTNAP1 (contactin associated protein 1) [NCBI Gene 8506] {aka CASPR, CHN3, CNTNAP, NRXN4, P190}, SLC6A3 (solute carrier family 6 member 3) [NCBI Gene 6531] {aka DAT, DAT1, PKDYS, PKDYS1}, AVP (arginine vasopressin) [NCBI Gene 551] {aka ADH, ARVP, AVP-NPII, AVRP, VP}
- **Diseases:** chest pain (MESH:D002637), myositis (MESH:D009220), fatigue (MESH:D005221), tetraparesis (MESH:C565722), Stroke (MESH:D020521), left ventricular dysfunction (MESH:D018487), leukoencephalopathy (MESH:D056784), nausea (MESH:D009325), AN (MESH:D001327), arrhythmias (MESH:D001145), hemorrhagic complications (MESH:D006470), autosomal recessive neurodegenerative disorder (MESH:D020271), obesity (MESH:D009765), NPC (MESH:D052556), temporal epilepsy (MESH:C536956), tetraplegia (MESH:D011782), mood, anxiety, psychotic, and substance use disorders (MESH:D001008), burn-out syndrome (MESH:D002056), Neurological disorders (MESH:D009461), ischaemia (MESH:D007511), seizure (MESH:D012640), fever (MESH:D005334), Pain (MESH:D010146), autoimmune neuropathies (MESH:D020274), sleep disorders (MESH:D012893), Pompe disease (MESH:D006009), Paroxysmal visual symptoms (MESH:D014786), PD (MESH:D010300), Mitochondrial Myopathy (MESH:D017240), CIDP (MESH:D020277), circulatory arrest (MESH:D012769), diseases (MESH:D004194), Neurological conditions (MESH:D019636), injury (MESH:D014947), inflammation (MESH:D007249), Headache (MESH:D006261), cystic echinococcosis (MESH:D004443), syncope (MESH:D013575), pain disorders (MESH:D013001), angina (MESH:D000787), cardiac arrest (MESH:D006323), preeclampsia (MESH:D011225), traumatic brain injury (MESH:D000070642), headache disorders (MESH:D020773), asthma (MESH:D001249), meningitis (MESH:D008580), anxiety (MESH:D001007), neuroinflammation (MESH:D000090862), infectious encephalitis (MESH:D000069544), brain atrophy (MESH:C566985), mental disorders (MESH:D001523), renal failure (MESH:D051437), unconscious (MESH:D014474), AD (MESH:D000544), cardiogenic shock (MESH:D012770), motion (MESH:D009041), leg weakness (MESH:D018908), polyneuropathies (MESH:D011115), diabetes (MESH:D003920), neurosyphilis (MESH:D009494)
- **Chemicals:** fludarabine (MESH:C024352), acyclovir (MESH:D000212), cyclophosphamide (MESH:D003520), miglustat (MESH:C059896), Lu (MESH:D008187), elamipretide (MESH:C506540), T (MESH:D014316), Lecanemab (MESH:C000612089), aldosterone (MESH:D000450), adrenaline (MESH:D004837), 18Flurodeoxyglucose (-), ocrelizumab (MESH:C533411), 18F-fluorodeoxyglucose (MESH:D019788), catecholamine (MESH:D002395), ADLL (MESH:C088117), Rituximab (MESH:D000069283)
- **Species:** Homo sapiens (human, species) [taxon 9606], Betapolyomavirus hominis (species) [taxon 1891762]
- **Mutations:** T/G, rs3115534
- **Cell lines:** SPS05_5 — Lateolabrax japonicus (Japanese sea perch), Spontaneously immortalized cell line (CVCL_R927)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12181744/full.md

---
Source: https://tomesphere.com/paper/PMC12181744